Guggenheim Defensive Equity ETF (DEF)

Delayed Data
As of Mar 27
 +0.0087 / +0.02%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the performance, before the fund's fees and expenses, of an equity index called the Sabrient Defensive Equity Index. The fund will invest at least 90% of its total assets in common stock, ADRs and MLPs that comprise the index and depositary receipts representing common stocks included in the index. The index is comprised of approximately 100 securities selected, based on investment and other criteria developed by Sabrient Systems LLC, from a broad universe of U.S.-traded securities, including master limited partnerships ("MLPs") and American depositary receipts ("ADRs").

No recent news for Guggenheim Defensive Equity ETF.


1 month-0.98% 3 years+13.70%
3 months-0.10% 5 years+14.40%
1 year+13.41% Since inception+7.52%
Data through 03/28/2015

Quote Details

Previous close$38.29
Open day’s range38.19 – 38.37
Net asset value (NAV)38.32 (03/27/2015)
Daily volume9,709
Average volume (3 months)47,417
Data as of 3:29pm ET, 03/27/2015

Peer Comparisonvs. Large value ETFs

Performance 5-yr return+14.40%+15.11%
Expense Gross exp ratio0.74%0.38%
Risk 5 year sharpe ratio1.581.24
Net assets$230.3M$2.4B
Average market cap$22.8B$84.3B
Average P/E18.616.7
Dividend / Share--0.27%


RWL RevenueShares Large Cap Fund
SCHV Schwab U.S. Large-Cap Value ETF™
VTV Vanguard Value Index Fund ETF Shares


Top 5 Sectors
Portfolio weighting
Utilities 25.27%
Energy 14.22%
Financial service 12.97%
Consumer goods 12.67%
Telecommunication 7.38%
Top 10 Holdings
Portfolio weighting
KSS Kohls Corp1.21%
MBT Mobile TeleSystems OAO1.20%
BT BT Group PLC1.13%
MFG Mizuho Financial Group Inc1.13%
CHU China Unicom Hong Kong Ltd1.11%
WBK Westpac Banking Corp1.10%
GSK GlaxoSmithKline1.09%
PFE Pfizer1.09%
SYT Syngenta AG1.09%
CA CA Inc1.08%

To view my watchlist

Not a member yet?

Sign up now for a free account